AGH BioConsulting Ltd 14634123 false 2024-03-01 2025-02-28 2025-02-28 The principal activity of the company is Professional scientific and technical activities. Digita Accounts Production Advanced 6.30.9574.0 true 14634123 2024-03-01 2025-02-28 14634123 2025-02-28 14634123 core:CurrentFinancialInstruments core:WithinOneYear 2025-02-28 14634123 bus:Micro-entities 2024-03-01 2025-02-28 14634123 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 14634123 bus:FullAccounts 2024-03-01 2025-02-28 14634123 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 14634123 bus:RegisteredOffice 2024-03-01 2025-02-28 14634123 bus:Director1 2024-03-01 2025-02-28 14634123 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 14634123 countries:AllCountries 2024-03-01 2025-02-28 14634123 2023-03-01 2024-02-29 14634123 2024-02-29 14634123 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 iso4217:GBP xbrli:pure

Registration number: 14634123

AGH BioConsulting Ltd

Unaudited Filleted Financial Statements

for the Year Ended 28 February 2025

 

AGH BioConsulting Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

AGH BioConsulting Ltd

Company Information

Director

Mr Antony Gordon Hitchcock

Registered office

3 Crewe Road
Sandbach
Cheshire
CW11 4NE

 

AGH BioConsulting Ltd

(Registration number: 14634123)
Balance Sheet as at 28 February 2025

2025
£

2024
£

Fixed assets

424

682

Current assets

20,686

10,032

Prepayments and accrued income

3,043

7,758

Creditors: Amounts falling due within one year

(6,813)

(5,438)

Net current assets

16,916

12,352

Total assets less current liabilities

17,340

13,034

Provisions for liabilities

(81)

(130)

Accruals and deferred income

-

(150)

 

17,259

12,754

Capital and reserves

17,259

12,754

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
3 Crewe Road
Sandbach
Cheshire
CW11 4NE
United Kingdom

These financial statements were authorised for issue by the director on 2 April 2025.

Basis of preparation

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

For the financial year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

AGH BioConsulting Ltd

(Registration number: 14634123)
Balance Sheet as at 28 February 2025

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 2 April 2025
 

.........................................
Mr Antony Gordon Hitchcock
Director